Can CNNM2 and TRPM6 variants reduce magnesium handling reserve?

Magnesium homeostasis depends on active transcellular transport in the kidneys and intestines, which is tightly regulated by specific epithelial transport proteins.

Mechanistic pathways of magnesium transport

• Apical entry: TRPM6 is an apically localized, magnesium-selective chanzyme that mediates the rate-limiting, active magnesium ($Mg^{2+}$) entry from the lumen of the colon and the renal distal convoluted tubule (DCT).
• Basolateral extrusion: CNNM2 is localized to the basolateral membrane of renal DCT cells and colonic epithelia, where it mediates or regulates sodium-dependent magnesium extrusion into the bloodstream, completing the transcellular loop.

Impact of genetic variants on magnesium reserve

• Severe pathogenic mutations: Loss-of-function mutations in TRPM6 disrupt apical entry, causing autosomal recessive hypomagnesemia with secondary hypocalcemia. Conversely, mutations in CNNM2 impair basolateral extrusion, leading to dominant renal magnesium wasting.
• Subtle polymorphisms: Beyond rare Mendelian disorders, common genetic polymorphisms, such as the TRPM6 variant rs3750425, exert context-dependent effects. These variants reduce the functional magnesium handling reserve, rendering individuals highly susceptible to hypomagnesemia during periods of low dietary intake or increased metabolic demand.

Bottom line

• Genetic variants in CNNM2 and TRPM6 directly compromise apical magnesium entry and basolateral extrusion in the kidneys and intestines, significantly depleting the systemic magnesium handling reserve and increasing susceptibility to hypomagnesemia.